文献速递血液透析通路

贵要静脉抬高转位可改善贵要静脉动静脉瘘浅表化的临床结局

Basilic elevation transposition may improve the clinical outcomes for superficialization of basilic arteriovenous fistula veins.
PubMed 文献 · J Vasc Surg · 2016-12-29

本研究在门诊手术中心回顾性分析了2009年2月至2016年1月接受二期贵要静脉转位的99例患者,比较贵要静脉抬高转位(BET)与贵要静脉隧道转位(BTT)的临床结局。

核心结论

  • BET是一种可靠的浅表化方法,可获得较高的累积瘘管生存率。
  • 与BTT相比,BET与贵要静脉一期通畅率改善和血管内干预需求减少相关。

研究设计与样本

  • 回顾性收集2009年2月至2016年1月在门诊手术中心接受二期贵要静脉转位患者的 demographic 和结局数据并分析。
  • 共纳入99例患者,平均年龄61±16岁,53%为男性,64%为糖尿病患者;27例行BTT,72例行BET;平均随访26.2±20.5个月(范围1-83个月)。

主要发现

  • 全瘘管1年一期、辅助一期和二期通畅率:BTT组分别为26%、91%、100%,BET组分别为46%、98%、100%。
  • 全瘘管2年一期、辅助一期和二期通畅率:BTT组分别为21%、80%、94%,BET组分别为38%、98%、98%。

临床怎么用

  • 在行贵要静脉动静脉瘘浅表化时,可优先考虑BET以改善贵要静脉一期通畅率并减少血管内干预。

局限性

  • 本研究为单中心、单术者回顾性分析,样本量有限(99例),可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Basilic vein arteriovenous fistulas are an important and common option for hemodialysis access and require superficialization before use. Various superficialization techniques have been employed, such as basilic tunnel transposition (BTT), basilic elevation, and basilic elevation transposition (BET). Each technique may have advantages and disadvantages, and there have been few reports directly comparing the outcomes of these techniques. This report compares the clinical outcomes of BET vs BTT performed by a single operator and discusses some technical considerations derived from this study and the literature. METHODS: The demographic and outcome data of patients who underwent second-stage basilic vein transposition at an ambulatory surgery center from February 2009 to January 2016 were collected and analyzed. RESULTS: Of the 99 patients identified, 53% were male and 64% were diabetic; the mean age was 61 ± 16 years; 27 had BTT and 72 had BET; the mean follow-up was 26.2 ± 20.5 (range, 1-83) months. The primary patency, assisted primary patency, and secondary patency rates of the whole fistula conduit were 26%, 91%, and 100% for the BTT group and 46%, 98%, 100% for the BET group at 1 year and 21%, 80%, 94% for the BTT group and 38%, 98%, 98% for the BET group at 2 years. The primary patency rate of the basilic vein (segment of the fistula conduit superficialized by transposition) at 1 year was significantly lower for the BTT group vs the BET group (26% vs 61%; P = .004). The average number of percutaneous interventions required for the basilic vein was significantly more for the BTT group vs the BET group (1.5 ± 1.3 vs 0.6 ± 1.0/access-year; P = .007). Based on a Cox regression analysis, the surgical techniques were the only clinical factor that significantly affected the basilic vein primary patency (hazard ratio of 2.28 in favor of BET over BTT; 95% confidence interval, 1.25-4.14; P = .007). CONCLUSIONS: BET is a reliable approach that yields a high cumulative fistula survival rate. Compared with BTT, BET is associated with improved basilic vein primary patency and reduced need for endovascular interventions.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Wang S, Wang MS, Jennings WC, et al. Basilic elevation transposition may improve the clinical outcomes for superficialization of basilic arteriovenous fistula veins. J Vasc Surg. 2016. PMID: 28041805. doi:10.1016/j.jvs.2016.10.081

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。